AMRX logo

Amneal Pharmaceuticals (AMRX) Company Overview

Profile

Full Name:

Amneal Pharmaceuticals, Inc.

Sector:

Healthcare

Country:

United States

IPO:

May 7, 2018

Indexes:

Not included

Description:

Amneal Pharmaceuticals (AMRX) is a global healthcare company that develops, manufactures, and markets generic and specialty pharmaceuticals. They focus on providing affordable medications across various therapeutic areas, aiming to improve patient access to essential treatments while ensuring high-quality standards in their products.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 28, 2025

Recent annual earnings:

Feb 28, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 24, 25 JP Morgan
Overweight
Nov 11, 24 Piper Sandler
Overweight
Oct 2, 24 Truist Securities
Buy
Sep 6, 24 JP Morgan
Neutral
Aug 13, 24 Barclays
Overweight
Aug 12, 24 Truist Securities
Buy
May 6, 24 Truist Securities
Buy
May 6, 24 Goldman Sachs
Buy
Mar 21, 24 Piper Sandler
Overweight
Mar 4, 24 Goldman Sachs
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Amneal Pharmaceuticals?
  • Does Amneal Pharmaceuticals pay dividends?
  • What sector is Amneal Pharmaceuticals in?
  • What industry is Amneal Pharmaceuticals in?
  • What country is Amneal Pharmaceuticals based in?
  • When did Amneal Pharmaceuticals go public?
  • Is Amneal Pharmaceuticals in the S&P 500?
  • Is Amneal Pharmaceuticals in the NASDAQ 100?
  • Is Amneal Pharmaceuticals in the Dow Jones?
  • When was Amneal Pharmaceuticals's last earnings report?
  • When does Amneal Pharmaceuticals report earnings?
  • Should I buy Amneal Pharmaceuticals stock now?

What is the ticker symbol for Amneal Pharmaceuticals?

The ticker symbol for Amneal Pharmaceuticals is NYSE:AMRX

Does Amneal Pharmaceuticals pay dividends?

No, Amneal Pharmaceuticals does not pay dividends

What sector is Amneal Pharmaceuticals in?

Amneal Pharmaceuticals is in the Healthcare sector

What industry is Amneal Pharmaceuticals in?

Amneal Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry

What country is Amneal Pharmaceuticals based in?

Amneal Pharmaceuticals is headquartered in United States

When did Amneal Pharmaceuticals go public?

Amneal Pharmaceuticals's initial public offering (IPO) was on May 7, 2018

Is Amneal Pharmaceuticals in the S&P 500?

No, Amneal Pharmaceuticals is not included in the S&P 500 index

Is Amneal Pharmaceuticals in the NASDAQ 100?

No, Amneal Pharmaceuticals is not included in the NASDAQ 100 index

Is Amneal Pharmaceuticals in the Dow Jones?

No, Amneal Pharmaceuticals is not included in the Dow Jones index

When was Amneal Pharmaceuticals's last earnings report?

Amneal Pharmaceuticals's most recent earnings report was on Feb 28, 2025

When does Amneal Pharmaceuticals report earnings?

The date for Amneal Pharmaceuticals's next earnings report has not been announced yet

Should I buy Amneal Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions